Nine Monthly Results Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is -3.16% vs 7.28% in Dec 2024
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is -5.13% vs 1.55% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 8.84% vs 24.90% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 83.08% vs -51.13% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Novartis India With
Figures in Cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
263.78
1,204.48
-940.70
-78.10%
Other Operating Income
0.00
32.46
-32.46
-100.00%
Total Operating income
263.78
1,236.94
-973.16
-78.67%
Raw Material Cost
0.00
254.98
-254.98
-100.00%
Purchase of Finished goods
142.24
111.04
31.20
28.10%
(Increase) / Decrease In Stocks
3.95
-3.38
7.33
216.86%
Employee Cost
16.73
292.65
-275.92
-94.28%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
61.78
-61.78
-100.00%
Other Expenses
27.38
425.75
-398.37
-93.57%
Total Expenditure (Excl Depreciation)
190.30
1,142.82
-952.52
-83.35%
Operating Profit (PBDIT) excl Other Income
73.48
94.12
-20.64
-21.93%
Other Income
28.76
19.29
9.47
49.09%
Operating Profit (PBDIT)
102.24
113.41
-11.17
-9.85%
Interest
1.19
65.77
-64.58
-98.19%
Exceptional Items
0.00
-6.54
6.54
100.00%
Gross Profit (PBDT)
101.05
41.10
59.95
145.86%
Depreciation
1.53
80.19
-78.66
-98.09%
Profit Before Tax
99.52
-39.09
138.61
354.59%
Tax
31.59
-6.08
37.67
619.57%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
67.93
-33.01
100.94
305.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
67.93
-33.01
100.94
305.79%
Equity Capital
12.34
18.45
-6.11
-33.12%
Face Value
5.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
27.86%
7.61%
0.00
20.25%
Gross Profit Margin
38.31%
3.32%
0.00
34.99%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 263.78 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -3.16% vs 7.28% in Dec 2024
Nine Monthly - Standalone Net Profit
Standalone Net Profit 67.93 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -5.13% vs 1.55% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 73.48 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 8.84% vs 24.90% in Dec 2024
Nine Monthly - Interest
Interest 1.19 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 83.08% vs -51.13% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.86%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
